Skip to main contentSkip to navigationSkip to search

Transparency reporting

Below is information containing Camurus' disclosures of transfers of values, which is made available in accordance with applicable laws, regulations and/or industry code. In addition, more detailed information regarding Camurus' grants and donations to healthcare and patient organizations, and Investigator Sponsored Studies are disclosed below. 

corporate


Grants and donations to healthcare and patient organizations

See below for information on grants and donations provided by Camurus AB since January 2022, including requests for such support which have been received by the company’s subsidiaries. 

The disclosure includes grants and donations given to healthcare organizations (eg. healthcare, medical or scientific association or society, hospital, clinic, foundation, university or other teaching institution), or similar (e.g. research institutions in the field of medicine), and patient organizations and similar.

During 2023, the list below will be updated regularly, as new projects have been granted support by Camurus and are agreed with the recipient organization. 

Previous years: 

Grants disclosures 2023 (pdf)
Grants disclosures 2022 (pdf)

Grants disclosures and donations 2024
 Approval dateOrganization (recipient) Country/ region (recipient) 

Patient organization
(Yes/No)

Grant project description Purpose/categoryAmount 
27 November 2024

PCM Scientific 

UKNo“IOTOD 2024 CME program and winter webinar” 

Educational /Event  

9,850 GBP 
11 November 2024

Sunnybrook Health Sciences Centre 

USNo“Neuroendocrine Cancer (NETs) fellowship program” Educational/Research 75,000 CAD 
-

Les Restos du Cœur 

France No-Camurus' Value Award donation Q3 2024 200 EUR 
16 October 2024

Scottish Drugs Forum 

UKNo“Amplifying Voices of People with Lived and Living Experience of Substance Use” “Amplifying Voices of People with Lived and Living Experience of Substance Use” 75,000 GBP 
3 September 2024

Church on The Street 

UKNo“COTS Educational Programme” Educational 15,000 GBP 
16 August 2024

Cleveland Clinic Educational Foundation 

USNo“Contemporary Issues in Pituitary Disease” 

Educational /Event 

2,500 USD 
13 August 2024

Gertox 

France No“Raise awareness around health and prison” “Raise awareness around health and prison” 10,000 EUR 
13 August 2024

DDN Magazine (CJ Wellings Ltd) 

UKNo“‘Know Your Meds’ Information Resource” Educational/Disease Awareness 28,300 GBP 
12 August 2024

JES Bundesverband 

GermanyYes“35 Jahre JES Netzwerk  - Vom „Junkie“ zum erfolgreichen Koopera onspartner Fachtag zur Jubiläum des bundesweiten JES Netzwerks” Educational/Event Educational/Event 
12 August 2024

ENETS / European Neuroendocrine Tumor Society e.V.

GermanyNo“NextGEN ENETS Scientific Workshop 2024”“NextGEN ENETS Scientific Workshop 2024”10,000 EUR
-

Nova Ukraine 

USNo-Camurus' Value Award donation Q2 2024 200 EUR 
29 July 2024

The Pituitary Society

USNo“7th Preceptorship Course for Fellows-in-Training”

Educational /Event 

30,000 USD
17 June 2024

Lived expert 

UKYes“Giving a voice to people in prison”

Research/Advocacy Support 

10,800 GBP 
31 May 2024

Phoenix Futures 

UKNo

“Anti-Stigma Network” 

Educational/Disease Awareness   10,000 GBP 
26 April 2024

ENETS / European Neuroendocrine Tumor Society e.V.  

GermanyNo“ENETS E-Learning Programme 2024” 

Educational /Event 
Disease Awareness Campaign 

5,000 EUR 
19 April 2024

Mainline 

The Netherlands No“Prison health break - Bringing back harm reduction to Dutch prison” 

Patient support
Communications/Advocacy support 

20,000 EUR 
-

Motor Neuron Disease (MND) New South Wales

AustraliaYes-

Camurus' Value Award donation Q1 2024

200 EUR
26 March 2024PCM Scientific UKNo“IOTOD 2024 EU Digital CME program” 

Educational

75,761 GBP 
26 March 2024President and Fellows of Harvard College acting through Harvard Medical School USNo“Clinical Endocrinology 2024” 

Educational/Event 

7,500 USD 
21 February 2024Netzwerk Neuroendokrine Tumoren (NeT) e.V. Germany Yes“21. Überregionaler Tumortag in Münster” Educational/Event 4,000 EUR 
12 February 2024Monash University Australia No“Stigma Training for General Practitioners (GPs) working in Victoria, Australia, to increase Medication Assisted Treatments of Opioid Dependence (MATOD)” Educational/Research 56,412.2 AUD 
2 February 2024PCM Scientific UKNo“IOTOD 2024 webinar series” Educational/Event 45,000 EUR 
19 January 2024Fonds Addict’AIDE FranceNo“Addiction expert patients” Patient support 5,000 EUR 
19 January 2024The General Hospital Corp dba Massachusetts General HospitalUSNo“Massachusetts General Hospital (MGH) Neuroendocrine Unit Physicians’ Pituitary Information Service (PPIS)”Educational5,000 USD
-Hjärt-LungfondenSwedenNo-Camurus' Value Award donation Q4 2023200 EUR
-McMillan Cancer SupportUKYes-Camurus' Value Award donation Q4 2023200 EUR
-NACOA GermanyYes-Camurus' Value Award donation Q4 2023200 EUR

Investigator Sponsored Studies (ISS)

Camurus has several Investigator Sponsored Studies (ISS) – research projects run by external researchers with support from Camurus ongoing, which aims to strengthen the  scientific evidence base. Camurus assists in these studies with financial support and/or with product, but is not involved in the design, execution, or interpretation of the results.

Investigator Sponsored Study (ISS) disclosure
ONGOING
Approval date/ contract signingOrganization (recipient) Country (recipient) Title of ISS Amount 
 23 June 2023University of Bordeaux France OBAP-A prospective observational study in naturalistic settings to describe Buvidal introduction in France: change in severity of addiction and health related quality of life over a period of 3 months 312,928.80 EUR
 13 December 2013LVR University Hospital Essen, University of Duisburg-Essen Germany Substitution im Alter - Substitution treatment in the elderly – Needs, fears and expectancies of an age-based treatment 12,000 EUR
FINISHED

Approval date/ contract signingOrganization (recipient) Country (recipient) Title of ISS Amount 
11 January 2023Medical University Centre Hamburg-Eppendorf (UKE)Germany Evaluation of treatment needs among opioid dependent drug users currently not in opioid substitution treatment83,900 EUR
 14 June 2023Monash University Australia Australian clinicians’ views, knowledge and experiences of long-acting injectable buprenorphine: How can care be optimised in the future? 99,983 EUR